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Human hookworm disease, a clinical condition caused by Ancylostoma duodenale or Necator americanus infection, affects up to 630 million people in the developing world (1) . Using their buccal cavities and hooklike teeth, the adult parasites attach themselves to villi in the small intestine. Each worm can then extract up to 0.20 ml of blood per day causing intestinal blood loss and ultimately iron-deficiency anemia and hypoalbuminemia (2, 3) .
To date the biochemical mechanism by which hookworms prevent blood coagulation while feeding remains unexplained. Previous studies have shown that extracts of the dog hookworm Ancylostoma caninum can prolong prothrombin time (PT) 1 (4-6), with variable effects on partial thromboplastin time (PTT) (4) (5) (6) , and interfere with collagen-or ADP-induced platelet aggregation, as well as inhibit the action of factor Xa (6) .
The recent finding of a proteolytic enzyme with anticlotting properties from the giant leech Haementeria ghilianii (7) led us to examine whether a similar proteolytic anticoagulant exists in the Ancylostoma hookworms. Data presented here suggests that the Ancylostoma hookworms secrete a 36,000 dalton protease which both interferes with fibrin clot formation and promotes fibrin clot dissolution. This proteolytic enzyme could be critical for continuous exsanguination from villous capillaries and therefore represents a potential target for immunological intervention.
Materials and Methods
Hookworms~ Third-stage infective filariform (La) larvae of A, duodenale were the gift of Dr. Gerhard Schad, University of Pennsylvania, School of Veterinary Medicine, Philadelphia (8) . Briefly, 1,000-1,500 La larvae were administered to 10-wk-old beagles reared helminth-naive (White Eagle Laboratories, Doylestown, PA) and immunocompromised with a daily oral dose of 5 mg prednisolone. 42 d after infection, the entire length of the small intestine was removed, slit longitudinally, and suspended in 0.85% NaCI at 37°C. Within 2 h the majority of adult worms released their grasp and were collected at the bottom of the cylinder. The living worms were individually rinsed in saline and were either used immediately or stored at -80°C.
La larvae of A. caninum were initially the gift of Dr. G. Schad, but were later cultured from embryonated eggs in the feces of infected pups (9) . The L3 larvae (1,500 2,000) were administered to mongrel pups, aged 2-12 mo. The pups were sacrificed 20 . Approximately t00-1,000 adult worms were incubated in phosphate-buffered saline (PBS) containing 100 U/ml penicillin and 100/.tg/ml streptomycin sulfate at 37°C for 22 h. The viability was 100% (as determined by motility) for the first 12 h, but began to slowly decline thereafter. At 22 h ~40-75% were viable. The fluid was removed from the settled worms and spun at 1,000 rpm for 10 min at 4°C in an IEC centrifuge to remove any debris, and stored at -80°C. The ES products had a protein content of 0.05-0.20 mg/ml when measured according to the method of Bradford (10) . Alternatively, aliquots were taken at various times to assess the proteolytic activity of the secreted material. Because of the difficulty in obtaining the human hookworm in quantity, ES products were not obtained from Electrophoretic Separation of Proteolytic Actwities. The protein composition of the homogenates and ES products were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (12) after silver staining (13) . Proteolytic activity in the gels was visualized by a modified procedure of Granelli-Piperno and Reich (14) . Aliquots of hookworm homogenates or ES products were added to 20 ~1 of a buffer containing 10% glycerol, 3% SDS, and 0.0625 M Tris-HC1 buffer, pH 6.8, and placed in an 80°C bath for 30 s. Samples were loaded onto 10% SDS-polyacrylamide slab gels not more than 0.75 mm in thickness and subjected to electrophoresis. After electrophoresis the gel was gently rocked in 2.5% aqueous Triton X-100 for 40 min at 22°C, rinsed thoroughly with distilled water, and then rocked in distilled water for an additional 30 min. At this time the get was removed and overlayed onto an agar plate containing casein (5.2 ml of 0.1 M Tris-HC1 buffer, pH 8.1, 3.6 ml of 2.5% agar, and 2.0 ml of 8% Carnation Instant Milk [boiled 10 minute~ in PBS]) and incubated at 37°C. Depending on enzyme concentration, bands of lysis corresponding to proteolytic activity appeared in 4-12 h. These bands were visualized better by staining with amido black, and then destaining with a solution of methanol, acetic acid, and water (70: 10:20).
aeSI-Fibrinogen Plates. Multi-well Linbro plates (Linbro Scientific, Inc., Hamden, CT) coated with 125I-fibrinogen were prepared by the method of Unkeless et al. (15) . Radioactivity in solution was determined with a Packard Auto-Gamma Scintillation Spectrometer (model 3002; Packard Instrument Co., Downers Grove, IL).
Electrophoretic Separation of Fibrinogen Fragments.
A solution of bovine fibrinogen (6.7 mg/ml) was incubated at 37°C in the presence of ES products (0.2 mg/ml). As controls, an equal amount of fibrinogen was incubated either alone or with plasmin. At indicated times aliquots were removed, added to buffer containing 10% glycerol, 3% SDS, and 0.0625 M Tris-HCl buffer, pH 6.8, and boiled for 5 min. The samples were subjected to SDS-PAGE.
Anticoagulant Activity of ES-generated Fibrinogen Degradation Products. Bovine fibrinogen (6.7 mg/ ml) was incubated either alone or with 0.01 vol of ES products (0.20 mg/ml protein) for 12-24 h at 37°C. PT were measured with various concentrations of citrated plasma and ES-generated fibrinogen degradation products or fibrinogen alone.
Electrophoretic Separation of Plasminogen Fragments. Plasminogen was purified from human
plasma by affinity chromatography (16) . The plasminogen (2.3 mg/ml) was incubated at 37°C in the presence of ES products (0.05 mg/ml protein). As controls, an equal amount of plasminogen was incubated either alone or with 1.0 mU urokinase. At indicated times aliquots were removed, added to buffer containing 10% glycerol, 5% 2-mercaptoethanol, 3% SDS, and 0.0625 M Tris-HCl buffer, pH 6.8, and boiled for 5 rain. The samples were subjected to SDS-PAGE.
Assessment of Elastolytic Actwity. Elastolytic activity of hookworm homogenates and ES products was determined using a synthetic peptide substrate covalently linked to a fluorescent leaving group (17). The rate of hydrolysis of methoxysuccinyl-L-alanyl-L-alanyl-h-prolyl-Lvaline-4-methylcoumarinyl-7-amide (meosucc-ala-ala-pro-val-AMC) (Vega Biochemicals, Tucson, AR) was measured spectrofluorimetrically in a Perkin-Elmer 204 fluorescence spectrophotometer (Perkin-Elmer Corp., Norwalk, CT). Various concentrations of either hookworm homogenates or ES products were added to a cuvette containing the substrate (10 50/zM) in buffer containing 0.05 M N-Tris (hydroxymethyl) methyl-2-aminoethane sulfonic acid (TES), 0.50 M NaCI, 0.03 0.10 M CaCIz at pH 7.0 with I0% vol/voI dimethyI sutfoxide at 22 ° or 37°C. The initial rate of increase in the 7-amino-4-methylcoumarin (AMC) concentration was monitored at excitation and emission wavelengths of 370 and 460 nm, respectively.
Results
Clotting Times. To determine whether Ancylostoma hookworms had an effect on fibrin clot formation, homogenates of A. duodenale were added to samples of normal citrated human plasma that were then assayed for PT and PTT. The addition of aliquots of the homogenates prolonged PT and PTT in a concentration-dependent manner (Fig. 1) . A prolongation of PT was also observed with ES products of A.
caninum (data not shown).
Electrophoretic Separation of Proteolytic Activity. The composition ofA. caninurn homogenates were analyzed by separation on SDS-PAGE (Fig. 2 A) . In lane a, ~40 major bands appeared after silver staining. Since it was suspected that Ancylostoma hookworms might secrete their anticoagulant, ES products were also analyzed. Compared with the crude homogenates, ES products contained fewer proteins (Fig. 2 A, lane b) . All 12 of the secreted proteins could be identified in the homogenates of the adult worms. The previous finding of an anticlotting protease from the leech (7) led us to investigate the possibility that some of the protein bands in Fig. 2A might have proteolytic activity. To analyze these proteolytic components, both A. caninum homogenates and ES products were separated on SDS-PAGE and overlayed onto casein agar (Fig. 2 B) . Examination ofproteolytic activity in the homogenates revealed seven bands (lane a) including three major components at 31,000, 36,000, and 40,000 daltons. Smaller amounts of proteolytic activity were associated with molecular mass bands at 21,000, 71,000, 91,000, and 102,000 daltons. Homogenates of A. duodenale showed a similar pattern of proteolytic activity (data not shown).
In contrast, only a single band of proteolytic activity was found in the ES products of A. caninum (Fig. 2B, lane b) . The apparent molecular mass of this protease was 36,000 daltons.
Anticlotting Properties of ES Products.
A number of experiments were undertaken to determine the specificity of the proteolytic activity which could account for the anticlotting effect. Using multi-well plates coated with 12sI-fibrinogen, both homogenates and ES products ofA. caninum were observed to degrade radiolabeled fibrinogen coated on plates (Fig. 3) . The amount of fibrinogen degraded was proportional to the amount of homogenate or ES products added, and showed no significant amplification by the addition of plasminogen (data not shown). This latter experiment rules out the possibility that the protease was acting as a plasminogen activator. The ability of ES products to degrade fibrinogen was also demonstrated using SDS-PAGE under nonreduced conditions (Fig. 4) . ES products (lane b) catalyzed the degradation of fibrinogen (Fig. 4, lane a) to five major components of molecular mass 223,000, 204,000, 156,000, 122,000, and 80,000 dahons (lanes d and e), and a minor component at 61,000 dahons (lane e). The molecular mass of fibrinogen alone incubated at 37°C remained unchanged throughout the experiment, and the molecular mass of the fibrinogen degradation products was different then those observed with plasmin-catalyzed degradation of fibrinogen (data not shown).
The fibrinogen degradation products resulting from ES digestion, by themselves increased PT. When 50 bd of fibrinogen (6.7 mg/ml), which had been previously incubated for 12-24 h at 37°C with 0.01 vol of ES products, were added to citrated plasma, the PT was prolonged 80% as compared with a 30% prolongation with 50 /zl of fibrinogen (6.7 mg/ml) incubated alone under similar conditions.
In addition to direct fibrinogenolysis, ES products also catalyzed the cleavage of plasminogen (Fig. 5) . After a 1 h incubation with plasminogen, two polypeptides of 40,000 and 58,000 daltons were formed (Fig. 5, lane b) . The molecular mass of the smaller fragment is similar to that reported for mini-plasminogen (18) which is formed w h e n l e u k o c y t e elastase cleaves p l a s m i n o g e n . T h i s 40,000 d a l t o n f r a g m e n t was o b s e r v e d b y t h e casein lysis t e c h n i q u e to h a v e p r o t e o l y t i c a c t i v i t y ( d a t a n o t s h o w n ) . I n a d d i t i o n to t h e t w o m a j o r b a n d s at 40,000 a n d 58,000 d a | t o n s , t w o m i n o r b a n d s a p p e a r e d at 39,000 a n d 65,000 d a h o n s . T h i s h e t e r o g e n e i t y m a y reflect t h e f i n d i n g that human plasminogen contains two major components, plasminogen a and b, which have slightly different molecular masses (19) . This cleavage by ES products was in contrast to the incubation of plasminogen with urokinase which resulted in two fragments of 68,000 and 28,000 daltons, corresponding to the heavy and light chain of plasmin, respectively (data not shown). Plasminogen alone showed no degradation during this incubation, Elastolytic Properties of ES Products. The catalytic cleavage ofplasminogen to a miniplasminogen-fike fragment suggested that ES products might have a proteolytic activity with elastolytic properties. Both hookworm homogenates and ES products could hydrolyze the synthetic substrate meosucc-ala-ala-pro-val-AMC, which has specificity for elastolytic enzymes (17). The specific activity for the hydrolysis of the substrate (20 ~tM) at 37°C was 0.02 nmol of AMC released/rain/rag protein and 0.21 nmol of AMC released/rain/rag protein for the homogenates and ES products, respectively. This is comparable to 21 nmol of AMC released/rain/rag protein using commercially purified porcine elastase (Elastin Products Co., Pacific, MS). The low activity observed for the purified enzyme reflects the suboptimal synthetic substrate concentrations (17) and the pH conditions (pH 7.0 instead of the optimal pH 8.8) used for the experiment. The time course of secretion in vitro by A. caninum of the elastolytic-like protease was followed using the synthetic substrate (Fig. 6) . A. caninum hookworms secrete the protease in linear fashion during the first 9 h in vitro. Subsequently, the amount of protease released decreases, probably reflecting a decrease in the viability of the worms. This increase in elastolytic activity with time in vitro was paralleled by increasing intensity of the zone of lysis at 36,000 dahons on SDS-PAGE with casein agar (data not shown).
Discussion
Evidence has been presented that the Ancylostoma hookworms secrete a 36,000 dalton proteolytic enzyme. It is hypothesized that this secreted protease may have a role Hours in vitro Fro. 6. Time course of protease secreted by A. camnum in vitro. 100 adult worms were incubated at 37°C in PBS containing 100 U/ml penicillin and 100/*g/ml streptomycin sulfate. 60-#1 aliquots were taken at 0.5, 1, 2, 5, 9, and 22 h and stored at -80°C. All samples were thawed and added to 3.0 ml of buffer containing 0.05 M TES, 0.S M NaC1, 0.1 M CaCI2, and 25 p,M meosucc-ala-alapro-val-AMC, and incubated at 22°C for 12 h. Fluorescence was monitored at excitation and emission wavelengths of 370 and 460 nm, respectively. related to the antihemostatic mechanism of the hookworm. Recently, anticoagulant activity from the giant leech Haementeria ghilianii (7) and the bacterium Streptococcus faecalis (20) has been attributed to a proteolytic enzyme that not only inhibits the clotting of plasma, but also dissolves previously formed fibrin clots. We examined the possibility that Ancylostorna ES products function in a similar manner. In this way proteolysis may act concurrently with previously reported anticoagulating properties of hookworm extracts, namely the inhibition ofplatelet aggregation (6) and factor Xa activity (6) , to ensure free blood flow into the bucca/cavity and alimentary canal of the parasite, In addition to the protease described above, other proteases with anticlotting activity might also be present in the ES products. This possibility exists since the casein-lysis technique utili2ed for the identification of the protease only detects proteolytic enzymes that are reactivated by removal of SDS.
The anticoagulant effects of hookworm ES products on plasma can be explained, in part, by a direct action on fibrinogen to produce nonclottable derivatives. When fibrinogen was incubated with ES products for various times, breakdown products ranging between 80,000 and 223,000 daltons were observed with SDS-PAGE. These products did not resemble the well characterized fragments observed with plasmin degradation (fragments X, Y, D, and E). Degradation of fibrinogen was also observed when a25I-fibrinogen coated on multi-well plates was incubated with ES products. These fibrinogen degradation products also increased PT.
In addition to direct fibrinogenolysis, ES products cleaved plasminogen to two fragments of 58,000 and 40,000 daltons. This smaller fragment resembles miniplasminogen, a product formed by leukocyte elastase digestion of plasminogen, which in turn can be activated by urokinase to form mini-plasmin. Mini-plasmin is not readily inhibited by a2-antiplasmin, the major physiologic inhibitor of plasmin in plasma (18, 21) , and may represent an asset to the hookworm whose survival necessitates destruction of a fibrin clot.
This catalytic conversion of plasminogen to a mini-plasminogen-like fragment led us to investigate whether the ES protease had elastolytic properties. The protease was found to hydrolyze meosucc-ala-ata-pro-val-AMC, a synthetic peptide substrate for elastolytic enzymes (I 7). The quantity of elastolytic-like activity released in vitro by the hookworms increased with time.
The elastolytic-like properties of the ES protease may be important in preventing clotting just as the analogous leukocyte elastase may have important anticoagulant properties (18, (21) (22) (23) (24) . Leukocyte elastase converts plasminogen to mini-plasminogen (18) , inactivates a2-antiplasmin and C1 inactivator (21) , degrades procoagulants (factors II, V, VII, VIII, XII, and XIII) (22) , and breaks down fibrinogen (23, 24) . Furthermore, the elastase-catalyzed products of fibrinogen digestion can also inhibit the thrombin-catalyzed conversion of fibrinogen of fibrin (24) . A biochemical comparison of leukocyte elastase and the ES protease from hookworms is currently in progress.
From a medical and veterinary standpoint, the proteolytic anticoagulant of the hookworm represents a unique feature available to natural and induced immunological intervention. In support of this is the fact that dogs with repeated infections became immune to A. caninum infection (25) , and sera from these dogs neutralized proteolytic enzyme activity in esophagea! extracts from the parasite (26, 27) . Presumably, during feeding ES products are introduced into the host and elicit protective antibodies. It is possible that these protective antibodies inhibit the 36,000 dalton ES protease, block the antihemostatic mechanism, allow clot formatin, and starve the parasite. This possibility is under investigation.
Summary
Hookworms of the genus Ancylostoma secrete an anticoagulant that both inhibits the clotting of human plasma and promotes fibrin clot dissolution. This anticoagulant activity is attributable to a 36,000 dalton proteolytic enzyme. The protease can degrade fibrinogen into five smaller polypeptides that intrinsically have anticoagulating properties, covert plasminogen to a mini-plasminogen-like molecule, and hydrolyze a synthetic peptide substrate with specificity for elastolytic enzymes. It is hypothesized that the parasite uses this enzyme to prevent blood clotting while feeding on villous capillaries.
